Alpha Healthcare III (ALPA) to Combine with Carmell Therapeutics in $188M Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) has entered into a definitive agreement to combine with drug developer Carmell at an enterprise value of $188.4 million. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds. The combined company is expected to trade on the Nasdaq under the symbol
Read More